Costs and Expenses in USD of Cardlytics, Inc. from 2016 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Cardlytics, Inc. quarterly and annual Costs and Expenses history and change rate from 2016 to Q3 2025.
  • Cardlytics, Inc. Costs and Expenses for the quarter ending 30 Sep 2025 was $120,885,000, a 44% decline year-over-year.
  • Cardlytics, Inc. Costs and Expenses for the twelve months ending 30 Sep 2025 was $355,212,000, a 39% decline year-over-year.
  • Cardlytics, Inc. annual Costs and Expenses for 2024 was $473,797,000, a 6.5% increase from 2023.
  • Cardlytics, Inc. annual Costs and Expenses for 2023 was $444,874,000, a 41% decline from 2022.
  • Cardlytics, Inc. annual Costs and Expenses for 2022 was $756,320,000, a 94% increase from 2021.
Source SEC data
View on sec.gov
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Change (%)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Change (%)

Cardlytics, Inc. Quarterly Costs and Expenses (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $355,212,000 $120,885,000 -$94,718,000 -44% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $449,930,000 $76,038,000 -$9,410,000 -11% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $459,340,000 $75,977,000 -$14,457,000 -16% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $473,797,000 $82,312,000 -$109,777,000 -57% 01 Oct 2024 31 Dec 2024 10-K 12 Mar 2025 2024 FY
Q3 2024 $583,574,000 $215,603,000 +$115,946,000 +116% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $467,628,000 $85,448,000 -$15,576,000 -15% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 $483,204,000 $90,434,000 +$38,330,000 +74% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q4 2023 $444,874,000 $192,089,000 -$273,049,000 -59% 01 Oct 2023 31 Dec 2023 10-K 12 Mar 2025 2024 FY
Q3 2023 $717,923,000 $99,657,000 +$38,471,000 +63% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 $679,452,000 $101,024,000 -$96,700,000 -49% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $776,152,000 $52,104,000 +$19,832,000 +61% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q4 2022 $756,320,000 $465,138,000 +$358,680,000 +337% 01 Oct 2022 31 Dec 2022 10-K 12 Mar 2025 2024 FY
Q3 2022 $397,640,000 $61,186,000 -$43,591,000 -42% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 $441,231,000 $197,724,000 +$94,643,000 +92% 01 Apr 2022 30 Jun 2022 10-Q 01 Aug 2023 2023 Q2
Q1 2022 $346,588,000 $32,272,000 -$43,127,000 -57% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $389,715,000 $106,458,000 +$33,259,000 +45% 01 Oct 2021 31 Dec 2021 10-K 14 Mar 2024 2023 FY
Q3 2021 $356,456,000 $104,777,000 +$42,559,000 +68% 01 Jul 2021 30 Sep 2021 10-Q 01 Nov 2022 2022 Q3
Q2 2021 $313,897,000 $103,081,000 +$55,121,000 +115% 01 Apr 2021 30 Jun 2021 10-Q 02 Aug 2022 2022 Q2
Q1 2021 $258,776,000 $75,399,000 +$17,961,000 +31% 01 Jan 2021 31 Mar 2021 10-Q 02 May 2022 2022 Q1
Q4 2020 $240,815,000 $73,199,000 +$5,162,000 +7.6% 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
Q3 2020 $235,653,000 $62,218,000 -$799,000 -1.3% 01 Jul 2020 30 Sep 2020 10-Q 02 Nov 2021 2021 Q3
Q2 2020 $236,452,000 $47,960,000 -$6,252,000 -12% 01 Apr 2020 30 Jun 2020 10-Q 03 Aug 2021 2021 Q1
Q1 2020 $242,704,000 $57,438,000 +$14,949,000 +35% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021 2021 Q1
Q4 2019 $227,755,000 $68,037,000 +$9,410,000 +16% 01 Oct 2019 31 Dec 2019 10-K/A 02 May 2022 2021 FY
Q3 2019 $218,345,000 $63,017,000 +$19,777,000 +46% 01 Jul 2019 30 Sep 2019 10-Q 02 Nov 2020 2020 Q3
Q2 2019 $198,568,000 $54,212,000 +$7,008,000 +15% 01 Apr 2019 30 Jun 2019 10-Q 04 Aug 2020 2020 Q2
Q1 2019 $191,560,000 $42,489,000 -$41,000 -0.1% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q4 2018 $191,601,000 $58,627,000 +$17,166,000 +41% 01 Oct 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
Q3 2018 $174,435,000 $43,240,000 +$9,295,000 +27% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $165,140,000 $47,204,000 +$9,075,000 +24% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019 2019 Q2
Q1 2018 $156,065,000 $42,530,000 +$8,601,000 +25% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q4 2017 $147,464,000 $41,461,000 01 Oct 2017 31 Dec 2017 10-K 03 Mar 2020 2019 FY
Q3 2017 $33,945,000 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2018 Q3
Q2 2017 $38,129,000 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 $33,929,000 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1

Cardlytics, Inc. Annual Costs and Expenses (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $473,797,000 +$28,923,000 +6.5% 01 Jan 2024 31 Dec 2024 10-K 12 Mar 2025 2024 FY
2023 $444,874,000 -$311,446,000 -41% 01 Jan 2023 31 Dec 2023 10-K 12 Mar 2025 2024 FY
2022 $756,320,000 +$366,605,000 +94% 01 Jan 2022 31 Dec 2022 10-K 12 Mar 2025 2024 FY
2021 $389,715,000 +$148,900,000 +62% 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2024 2023 FY
2020 $240,815,000 +$13,060,000 +5.7% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $227,755,000 +$36,154,000 +19% 01 Jan 2019 31 Dec 2019 10-K/A 02 May 2022 2021 FY
2018 $191,601,000 +$44,137,000 +30% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
2017 $147,464,000 -$21,589,000 -13% 01 Jan 2017 31 Dec 2017 10-K 03 Mar 2020 2019 FY
2016 $169,053,000 01 Jan 2016 31 Dec 2016 10-K 05 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.